A trial of a U.K.-developed coronavirus vaccine has found that it is safe and induces an immune reaction, according to preliminary results. Speaking to reporters on Monday, World Health Organization (WHO) emergencies programme executive director Michael Ryan called it “good news” while stating that the initial trial did not appear to have “any serious adverse events.” He added that there is “a long way to go,” but that it is good to see more data “in this very important phase of vaccine discovery.”
Health
Coronavirus: WHO hails ‘good news’ on COVID-19 vaccines, but warns there’s still a long way to go
More Videos
-
King Charles says his cancer treatment will ease in 2026
-
Looking back at Canada’s response to the measles outbreak
-
Milestone donation achieved at Canadian Blood Services
-
‘Game changer’: 3D-printing breakthrough could transform chronic lung disease
-
Health Matters: Canadian health workforce numbers struggling to meet demand, CIHI report says
-
Health Matters: Alberta government invokes notwithstanding clause for 4th time
You are viewing an Accelerated Mobile Webpage.
View Original Article